2.5. Study selection and management
This protocol is extracted from research article:
Chinese herbal medicine injections (CHMIs) for chronic pulmonary heart disease
Medicine (Baltimore), Jan 22, 2021; DOI: 10.1097/MD.0000000000024128

First of all, all qualified documents will be extracted in the form of title and abstract, and preliminary screening will be conducted based on this information. On the basis of the previous step, the full text of the qualified literature will be obtained and further screened. All screening processes will be performed independently by the 2 authors (Yuping Lei and Meili Wang), and the reasons for each rejection will be documented. Disagreements between the 2 reviewers will be resolved by discussing with the third investigator (Guiqiang Sun). A PRISMA-compliant flow chart (Fig. (Fig.1)1) will be used to describe the selection process of eligible literatures. Endnote X7 software will be used for literature managing and records searching.

Study selection process for the meta-analysis.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.